158 related articles for article (PubMed ID: 11827466)
41. A role for transcription factor GTF2IRD2 in executive function in Williams-Beuren syndrome.
Porter MA; Dobson-Stone C; Kwok JB; Schofield PR; Beckett W; Tassabehji M
PLoS One; 2012; 7(10):e47457. PubMed ID: 23118870
[TBL] [Abstract][Full Text] [Related]
42. The early embryonic expression of TFII-I during mouse preimplantation development.
Enkhmandakh B; Bitchevaia N; Ruddle F; Bayarsaihan D
Gene Expr Patterns; 2004 Jan; 4(1):25-8. PubMed ID: 14678824
[TBL] [Abstract][Full Text] [Related]
43. Genomic structure of the human p47-phox (NCF1) gene.
Chanock SJ; Roesler J; Zhan S; Hopkins P; Lee P; Barrett DT; Christensen BL; Curnutte JT; Görlach A
Blood Cells Mol Dis; 2000 Feb; 26(1):37-46. PubMed ID: 10772875
[TBL] [Abstract][Full Text] [Related]
44. A novel human gene, WSTF, is deleted in Williams syndrome.
Lu X; Meng X; Morris CA; Keating MT
Genomics; 1998 Dec; 54(2):241-9. PubMed ID: 9828126
[TBL] [Abstract][Full Text] [Related]
45. Cognitive-behavioral phenotypes of Williams syndrome are associated with genetic variation in the GTF2I gene, in a healthy population.
Crespi BJ; Hurd PL
BMC Neurosci; 2014 Nov; 15():127. PubMed ID: 25429715
[TBL] [Abstract][Full Text] [Related]
46. New TFII-I family target genes involved in embryonic development.
Makeyev AV; Bayarsaihan D
Biochem Biophys Res Commun; 2009 Sep; 386(4):554-8. PubMed ID: 19527686
[TBL] [Abstract][Full Text] [Related]
47. Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.
Howard ML; Palmer SJ; Taylor KM; Arthurson GJ; Spitzer MW; Du X; Pang TY; Renoir T; Hardeman EC; Hannan AJ
Neurobiol Dis; 2012 Mar; 45(3):913-22. PubMed ID: 22198572
[TBL] [Abstract][Full Text] [Related]
48. Variation in the Williams syndrome GTF2I gene and anxiety proneness interactively affect prefrontal cortical response to aversive stimuli.
Jabbi M; Chen Q; Turner N; Kohn P; White M; Kippenhan JS; Dickinson D; Kolachana B; Mattay V; Weinberger DR; Berman KF
Transl Psychiatry; 2015 Aug; 5(8):e622. PubMed ID: 26285132
[TBL] [Abstract][Full Text] [Related]
49. Structure, sequence, and chromosomal location of the gene for USF2 transcription factors in mouse.
Henrion AA; Martinez A; Mattei MG; Kahn A; Raymondjean M
Genomics; 1995 Jan; 25(1):36-43. PubMed ID: 7774954
[TBL] [Abstract][Full Text] [Related]
50. ChIP-Chip Identifies SEC23A, CFDP1, and NSD1 as TFII-I Target Genes in Human Neural Crest Progenitor Cells.
Makeyev AV; Bayarsaihan D
Cleft Palate Craniofac J; 2013 May; 50(3):347-50. PubMed ID: 23145914
[TBL] [Abstract][Full Text] [Related]
51. GTF2I hemizygosity implicated in mental retardation in Williams syndrome: genotype-phenotype analysis of five families with deletions in the Williams syndrome region.
Morris CA; Mervis CB; Hobart HH; Gregg RG; Bertrand J; Ensing GJ; Sommer A; Moore CA; Hopkin RJ; Spallone PA; Keating MT; Osborne L; Kimberley KW; Stock AD
Am J Med Genet A; 2003 Nov; 123A(1):45-59. PubMed ID: 14556246
[TBL] [Abstract][Full Text] [Related]
52. Genomic organization of the JEM-1 (BLZF1) gene on human chromosome 1q24: molecular cloning and analysis of its promoter region.
Tong JH; Fant X; Benoit G; Chen SJ; Chen Z; Lanotte M
Genomics; 2000 Nov; 69(3):380-90. PubMed ID: 11056056
[TBL] [Abstract][Full Text] [Related]
53. Complete physical map of the common deletion region in Williams syndrome and identification and characterization of three novel genes.
Meng X; Lu X; Li Z; Green ED; Massa H; Trask BJ; Morris CA; Keating MT
Hum Genet; 1998 Nov; 103(5):590-9. PubMed ID: 9860302
[TBL] [Abstract][Full Text] [Related]
54. Divergent human and mouse orthologs of a novel gene (WBSCR15/Wbscr15) reside within the genomic interval commonly deleted in Williams syndrome.
Doyle JL; DeSilva U; Miller W; Green ED
Cytogenet Cell Genet; 2000; 90(3-4):285-90. PubMed ID: 11124535
[TBL] [Abstract][Full Text] [Related]
55. Comparative genomic sequence analysis of the Williams syndrome region (LIMK1-RFC2) of human chromosome 7q11.23.
Martindale DW; Wilson MD; Wang D; Burke RD; Chen X; Duronio V; Koop BF
Mamm Genome; 2000 Oct; 11(10):890-8. PubMed ID: 11003705
[TBL] [Abstract][Full Text] [Related]
56. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug.
Barak B; Zhang Z; Liu Y; Nir A; Trangle SS; Ennis M; Levandowski KM; Wang D; Quast K; Boulting GL; Li Y; Bayarsaihan D; He Z; Feng G
Nat Neurosci; 2019 May; 22(5):700-708. PubMed ID: 31011227
[TBL] [Abstract][Full Text] [Related]
57. Alternative splicing and promoter use in TFII-I genes.
Makeyev AV; Bayarsaihan D
Gene; 2009 Mar; 433(1-2):16-25. PubMed ID: 19111598
[TBL] [Abstract][Full Text] [Related]
58. TFII-I regulates target genes in the PI-3K and TGF-β signaling pathways through a novel DNA binding motif.
Segura-Puimedon M; Borralleras C; Pérez-Jurado LA; Campuzano V
Gene; 2013 Sep; 527(2):529-36. PubMed ID: 23831514
[TBL] [Abstract][Full Text] [Related]
59. Regulation of alternative splicing of Gtf2ird1 and its impact on slow muscle promoter activity.
Tay ES; Guven KL; Subramaniam N; Polly P; Issa LL; Gunning PW; Hardeman EC
Biochem J; 2003 Sep; 374(Pt 2):359-67. PubMed ID: 12780350
[TBL] [Abstract][Full Text] [Related]
60. GTF2IRD1 in craniofacial development of humans and mice.
Tassabehji M; Hammond P; Karmiloff-Smith A; Thompson P; Thorgeirsson SS; Durkin ME; Popescu NC; Hutton T; Metcalfe K; Rucka A; Stewart H; Read AP; Maconochie M; Donnai D
Science; 2005 Nov; 310(5751):1184-7. PubMed ID: 16293761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
